- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03107767
Study of Re-operation Rate After Introduction of Evidence Based Algorithm for the Treatment of Ankle Fractures (PRO-Malleol)
The PRO-malleol Study
There is a high incidence of re-operations after surgery for ankle fractures. According to the Danish Fracture Database (DFDB) the re-operation rate, excluding hardware removal, is almost 10%.
We are conducting a study on the efficacy of an evidence based algorithm for the treatment of ankle fractures.
Study Overview
Status
Intervention / Treatment
Detailed Description
Treatment of ankle fractures is complex and includes assessment of fracture pattern, severity of soft-tissue involvement and general health- and functional status of the patients. Historically most fractures, undisplaced as well as displaced, were treated non-operatively with acceptable results but in recent years there is an increasing trend towards operative management of unstable fractures. Techniques for operative management of ankle fractures are varied and assessment of instability is mainly based on classic x-ray classification systems such as Lauge-Hansen or the AO that are difficult to reproduce[6].
We hypothesize that a standardized and evidence based approach to ankle fracture management will lead to a decrease in re-operation rate.
The aim of this study is to standardize the management of ankle fractures in our department, by introducing an algorithm based on best evidence present. We want to investigate:
- The effect of this algorithm on the re-operation rate of surgically treated ankle fractures in a two-year prospective observational setup with a minimum of one-year of follow-up.
- The need for surgery and functional outcome of patients with isolated lateral malleolus fractures in which the treatment is dictated by ankle stability assessed on weight bearing radiographs.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hvidovre, Denmark, 2650
- Recruiting
- Hvidovre University Hospital
-
Contact:
- Peter T Tengberg, MD
- Phone Number: +4561663676
- Email: ptofttengberg@gmail.com
-
Contact:
- Peter T Tengberg, MD
- Phone Number: +4522971007
- Email: peter.toft.tengberg@regionh.dk
-
Principal Investigator:
- Peter T Tengberg, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients treated for ankle fractures at our institution during the study period are asked to participate in the study.
Exclusion Criteria:
- Not speaking danish Not followed up at our institution Not mentally capable of filling out questionnaire
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Prospective Cohort
The prospective cohort following introduction of the evidence based algorithm for ankle fractures.
|
An evidence based algorithm for ankle fractures
|
|
No Intervention: Historical Cohort
Patients treated before introduction of algorithm.
Matched to prospective cohort for comparison
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in re-operation rate
Time Frame: one year
|
Change in re-operation rate following introduction of PRO malleol algorithm
|
one year
|
|
Rate of surgery for isolated lateral ankle fractures
Time Frame: one year
|
Rate of surgery for isolated lateral ankle fractures, following introduction of algorithm
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF 36
Time Frame: day 0 and 12 months
|
SF 36 before fracture and at 12 months
|
day 0 and 12 months
|
|
Ollerud Molander Ankle Score
Time Frame: Before fracture, 6 weeks, 12 weeks and 1 year
|
Before fracture, 6 weeks, 12 weeks and 1 year
|
|
|
Forgotten Joint Score
Time Frame: Before fracture, 6 weeks, 12 weeks and 1 year
|
Before fracture, 6 weeks, 12 weeks and 1 year
|
Before fracture, 6 weeks, 12 weeks and 1 year
|
|
Rate of complications not requiring surgery
Time Frame: One year
|
DVT, Nerve damage,
|
One year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO-Malleol study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
Clinical Trials on PRO-malleol algorithm
-
Rabin Medical CenterThe Leona M. and Harry B. Helmsley Charitable Trust; DreaMed DiabetesRecruiting
-
University of ArizonaWithdrawn
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
University of California, San FranciscoEko Devices, Inc.CompletedAortic Valve Stenosis | Mitral Regurgitation | Heart Murmurs | Valvular Heart DiseaseUnited States
-
ResMedCompletedObstructive Sleep Apnea (OSA)Australia
-
ResMedRecruitingObstructive Sleep ApneaAustralia
-
Johann Wolfgang Goethe University HospitalHemoSonics LLCTerminatedHemorrhage | BleedingGermany
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral RegurgitationCanada
-
University of OxfordUnknownHeart Failure, SystolicUnited Kingdom
-
Kıvanç AkçaHacettepe UniversityCompleted